SCHEMBL364281

SCHEMBL364281

COC(=O)c1c2ccccc2n2cc(C(C)=O)ccc12

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 4/20 0.48
KMT2A Q03164 7/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 2/20 0.46
SRC P12931 2/20 0.46
EGFR P00533 1/20 0.46
ALDH1A1 P00352 3/20 0.46
THRB P10828 1/20 0.46
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.43
F2 P00734 1/20 0.43
PLAU P00749 1/20 0.43
ELANE P08246 1/20 0.43
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL364927 0.92 SRC (0.51) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL364339 0.89 KMT2A (0.49) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL366141 0.87 NR4A2 (0.44) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL367569 0.87 SRC (0.46) NR4A2KMT2AKDM4ESRCEGFR
SCHEMBL364450 0.86 KMT2A (0.47) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL364265 0.86 NR4A2 (0.46) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL364770 0.85 ELANE (0.48) KMT2AKDM4EMEN1ALDH1A1MAPT
SCHEMBL366488 0.85 NR4A2 (0.45) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL365250 0.85 NR4A2 (0.45) NR4A2KMT2AKDM4EMEN1SRC
SCHEMBL366338 0.85 NR4A2 (0.45) NR4A2KMT2AKDM4EMEN1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed